TEST BANK Tietz Fundamentals Of CLINICAL CHEMISTRY AND MOLECULAR DIAGNOSTICS 7th Edition By Carl A. Burtis

TEST BANK
Tietz Fundamentals Of
CLINICAL CHEMISTRY AND
MOLECULAR DIAGNOSTICS
7th Edition By Carl A. Burtis




TEST BANK

,Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics 7th Edition Test Bank
WS WS WS WS WS WS WS WS
WS
WS WS




Table of contents: WS WS




I. Principles Of Laboratory Medicine
WS WS WS WS




Chapter 1. Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine
WS WS WS WS WS WS WS WS




Chapter 2. Selection and Analytical Evaluation of Methods — With Statistical Techniques
WS WS WS WS WS WS WS WS WS WS WS




Chapter 3. Clinical Evaluation of Methods
WS WS WS WS WS




Chapter 4. Evidence-Based Laboratory Medicine
WS WS WS WS




Chapter 5. Establishment and Use of Reference Values
WS WS WS WS WS WS WS




Chapter 6. Specimen Collection, Processing, and Other Preanalytical Variables
WS WS WS WS WS WS WS WS




Chapter 7. Quality Management
WS WS WS




II. Analytical Techniques And Instrumentation
WS WS WS WS




Chapter 8. Principles of Basic Techniques and Laboratory Safety
WS WS WS WS WS WS WS WS




Chapter 9. Optical Techniques
WS WS WS




Chapter 10. Electrochemistry and Chemical Sensors
WS WS WS WS WS




Chapter 11. Electrophoresis WS WS




Chapter 12. Chromatography WS WS




Chapter 13. Mass Spectrometry
WS WS WS




Chapter 14. Enzyme and Rate Analyses
WS WS WS WS WS




Chapter 15. Immunochemical Techniques
WS WS WS




Chapter 16 Automation WS WS




Chapter 17. Point-of-Care Instrumentation
WS WS WS




III. Analytes
W S




Chapter 18. Amino Acids, Peptides, and Proteins
WS WS WS WS WS WS




Chapter 19. Serum Enzymes WS WS WS




Chapter 20. Tumor Markers and Cancer Genes
WS WS WS WS WS WS




Chapter 21. Kidney Function Tests — Creatinine, GFR, Urea, and Uric Acid
WS WS WS WS WS WS WS WS WS WS WS




Chapter 22. Carbohydrates WS WS




Chapter 23. Lipids, Lipoproteins, Apolipoproteins, and Other Cardiac Risk Factors
WS WS WS WS WS WS WS WS WS




Chapter 24. Electrolytes and Blood Gases
WS WS WS WS WS




Chapter 25. Hormones WS WS




Chapter 26. Catecholamines and Serotonin
WS W S WS WS




Chapter 27. Vitamins, Trace Elements, Nutritional Assessment
WS W S WS WS WS WS




Chapter 28. Hemoglobin, Iron, and Bilirubin
WS WS WS WS WS




Chapter 29. Porphyrins and Porphyrias
WS WS WS WS




Chapter 30. Therapeutic Drugs and Their Management
WS WS WS WS WS WS




Chapter 31. Clinical Toxicology
WS WS WS




Chapter 32. Toxic Metals WS W S WS




IV. Pathophysiology
W S




Chapter 33. Diabetes WS WS

,Chapter 34. Cardiovascular Disease
WS W S WS




Chapter 35. Kidney Disease
WS WS WS




Chapter 36. Physiology and Disorders of Water, Electrolyte, and Acid-Base Metabolism
WS W S WS WS WS WS WS WS WS WS




Chapter 37. Liver Disease
WS W S WS




Chapter 38. Gastrointestinal and Pancreatic Diseases
WS W S WS WS WS




Chapter 39. Disorders of Bone and Mineral Metabolism
WS W S WS WS WS WS WS




Chapter 40. Disorders of the Pituitary Gland
WS W S WS WS WS WS




Chapter 41. Disorders of the Adrenal Cortex
WS W S WS WS WS WS




Chapter 42. Thyroid Disorders
WS W S WS




Chapter 43. Reproduction-Related Disorders
WS W S WS




Chapter 44. Pregnancy and Prenatal Testing
WS W S WS WS WS




Chapter 45. Newborn Screening and Inborn Errors of Metabolism
WS W S WS WS WS WS WS WS




Chapter 46. Pharmacogenetics
WS WS




V. Molecular Diagnostics
W S WS




Chapter 47. Principles of Molecular Biology
WS WS WS WS WS




Chapter 48. Nucleic Acid Techniques and Applications
WS WS WS WS WS WS




Chapter 49. Genomes and Nucleic Acid Alterations
WS WS WS WS WS WS

, Tietz Fundamentals of Clinical Chemistry and MolecularDiagnostics, 7e Burtis Test Bank
WS WS WS WS WS WS WS WS WS WS




Chapter 01: Clinical Chemistry, Molecular Diagnostics, and Laboratory MedicineTest Ban
WS WS WS WS WS WS WS WS WS




k

MULTIPLE CHOICE WS




1. An individual working in a clinical chemistry laboratory is married to a sales representative
WS WS WS WS WS WS WS WS WS WS WS WS WS WS




who works for a company that sells chemistry laboratory supplies. When the laboratory man
WS WS WS WS WS WS WS WS WS WS WS WS WS




ager requests a list of needed supplies, cost of supplies, and vendors, this individual only reco
WS WS WS WS WS WS WS WS WS WS WS WS WS WS WS




mmends the spouse’s company as the vendor. This is considered to be a(n):
WS WS WS WS WS WS WS WS WS WS WS WS




a. accounting issue. WS




b. possible conflict of interest. WS WS WS




c. maintenance of confidentiality issue. WS WS WS




d. problem with resource allocation. WS WS WS




ANS: B W S




Concern has been raised over the interrelationships between practitioners in the medical field an
WS WS WS WS WS WS WS WS WS WS WS WS WS




d commercial suppliers of drugs, devices, equipment, etc., to the medical profession.
WS WS WS WS WS WS WS WS WS WS WS




Similarly, relationships have been scrutinized between clinical laboratorians and manufacturer
WS WS WS WS WS WS WS WS WS




s and providers of diagnostic equipment and supplies. These concerns led the National Institut
WS WS WS WS WS WS WS WS WS WS WS WS WS




es of Health (NIH) in 1995 to require official institutional review of financial disclosure by res
WS WS WS WS WS WS WS WS WS WS WS WS WS WS WS




earchers and management of situations in which disclosure indicates potential conflicts of inter
WS WS WS WS WS WS WS WS WS WS WS WS




est.

DIF: 1 REF: W S Page 4-5 WS OBJ: 6 | 7 W S WS WS




2. A patient visits her physician stating that her prescribed painkiller is not working to reduce
WS WS WS WS WS WS WS WS WS WS WS WS WS WS WS




the pain following her recent surgery. A friend of the patient claims that the same painkiller
WS WS WS WS WS WS WS WS WS WS WS WS WS WS WS WS




“worked wonders” to reduce her pain after the same surgery. The physician states that the
WS WS WS WS WS WS WS WS WS WS WS WS WS WS WS




difference in the effect of the drug might be caused by
WS WS WS WS WS WS WS WS WS WS




, which is studied in pharmacoge WS WS WS WS WS




netics.
a. epidemiology
b. an inherited disease WS WS




c. a conflict of interest
WS WS WS




d. a genetic variation in drug-metabolizing enzymes
WS WS WS WS WS




ANS: D W S




Pharmacogenetics is the study of the genetic variation of drug metabolism between individ WS WS WS WS WS WS WS WS WS WS WS WS




uals.

DIF: 1 REF: W S W S Page 3 WS OBJ: 1 WS




3. John works in a molecular diagnostics laboratory and receives a blood sample that has the
WS WS WS WS WS WS WS WS WS WS WS WS WS WS WS




name of a close friend printed on the bar-
WS WS WS WS WS WS WS WS




coded label. The genetic test that is ordered on the friend’s sample would provide diagnosti
WS WS WS WS WS WS WS WS WS WS WS WS WS WS




c information about a disorder that has a poor prognosis, and the test is usually performed
WS WS WS WS WS WS WS WS WS WS WS WS WS WS WS WS




by John. He asks a fellow employee to analyze the sample for him and not divulge the resu
WS WS WS WS WS WS WS WS WS WS WS WS WS WS WS WS WS




lts. This ethical issue concerns:
WS WS WS WS




a. confidentiality of patient genetic and medical information. WS WS WS WS WS WS




b. a conflict of interest.
WS WS WS




c. resource allocation. WS




d. diagnostic accuracy. WS